Preventive Care
From the Journals
Can a Risk Score Predict Kidney Injury After Cisplatin?
Researchers have developed a risk algorithm to predict acute kidney injury after cisplatin administration and tested it using data from six US...
Feature
Do Health-Related Social Needs Raise Mortality Risk in Cancer Survivors?
Researchers examine links between mortality risk and health-related social needs in patients who had cancer.
Feature
Cervical Cancer Screening: US Clinicians Unclear About Best Practices
ACS guidelines mark a notable departure from prevailing practice.
Latest News
Vaccine Against Urinary Tract Infections in Development
The oral vaccine includes a suspension of whole heat-inactivated bacteria.
Feature
Routine Breast Cancer Screening Should Start at Age 40: USPSTF
Three JAMA editorials address concerns about the new recommendations.
From the Journals
Few Cancer Survivors Meet ACS Nutrition, Exercise Guidelines
Researchers estimate more than 9,000 survivors’ adherence to weight, physical activity, fruit and vegetable consumption, and alcohol intake...
Latest News
Automated Risk Assessment Tool Reduces Antibiotic Prescribing Rates
An EHR-based risk assessment tool aided clinicians in not prescribing an unnecessary broad-spectrum antibiotic, study states.
Latest News
Syphilis Treatment Falls Short for Pregnant Patients
Potential challenges to effective treatment of syphilis in pregnancy include drug shortages and time constraints.
Conference Coverage
Adding ACEI to Chemotherapy Does Not Prevent Cardiotoxicity
“We now have a definitive result in a robustly conducted trial that will take the field forward,” says an author of the new research.
Feature
What’s Driving the Higher Breast Cancer Death Rate in Black Women?
New research suggests that racial disparities in breast cancer are driven by more than socioeconomic factors.
From the Journals
Most Targeted Cancer Drugs Lack Substantial Clinical Benefit
Researchers assess validity of the molecular targets and clinical benefits of genome-targeted cancer drugs approved in the United States from 2015...